Tarar Ammar, Alyami Esmael M, Peng Ching-An
Department of Chemical and Biological Engineering, University of Idaho, 875 Perimeter Dr, Moscow, ID 83844, USA.
Methods Protoc. 2020 Dec 1;3(4):82. doi: 10.3390/mps3040082.
The limited amount of fusion protein transported into cytosol milieu has made it challenging to obtain a sufficient amount for further applications. To avoid the laborious and expensive task, T7 promoter-driving pET-30a(+) coding for chimeric gene of thymidine phosphorylase and core streptavidin as a model system was constructed and transformed into a variety of strains with T7 expression system. Our results demonstrated that the pET-30a(+)-TP-coreSA/Lemo21(DE3) system is able to provide efficient expression of soluble TP-coreSA fusion protein for purification. Moreover, the eluted TP-coreSA fusion protein tethered on biotinylated A549 carcinoma cells could effectively eliminate these malignant cells after administrating prodrug 5'-DFUR.
转运到胞质溶胶环境中的融合蛋白数量有限,这使得获得足够数量用于进一步应用具有挑战性。为避免这项费力且昂贵的任务,构建了由T7启动子驱动的编码胸苷磷酸化酶和核心链霉亲和素嵌合基因的pET-30a(+),并将其转化到多种带有T7表达系统的菌株中。我们的结果表明,pET-30a(+)-TP-coreSA/Lemo21(DE3)系统能够高效表达可溶性TP-coreSA融合蛋白以进行纯化。此外,在施用前药5'-DFUR后,连接在生物素化A549癌细胞上的洗脱的TP-coreSA融合蛋白能够有效消除这些恶性细胞。